GENEVA, Feb. 23 -- NOVARTIS AG (Lichtstrasse 354056 Basel) filed a patent application (PCT/IB2025/058142) for "SYNTHESIS AND CRYSTALLINE FORMS OF A CDK2 INHIBITOR" on Aug 11, 2025. With publication no. WO/2026/038120, the details related to the patent application was published on Feb 19, 2026.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Inventor(s): CASTAGNOLI, Carlo (Novartis Pharma AGLichtstrasse 354056 Basel), HARDEGGER, Leo Albert (Novartis Pharma AGLichtstrasse 354056 Basel), KORDIKOWSKI, Andreas (Novartis Pharma AGLichtstrasse 354056 Basel)
Abstract: The invention generally relates to crystalline fo...